無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

出生前DNAシーケンシングの世界市場:2018年〜2022年

Global Prenatal DNA Sequencing Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 640157
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.03円で換算しております。
Back to Top
出生前DNAシーケンシングの世界市場:2018年〜2022年 Global Prenatal DNA Sequencing Market 2018-2022
出版日: 2018年04月16日 ページ情報: 英文 121 Pages
概要

出生前DNAシークエンシングについて

出生前DNAシークエンシングは、妊娠中の女性の血液からDNAを単離し、胎児の完全な遺伝暗号を明らかにするDNAシークエンシングの方法です。これは、ダウン症候群、嚢胞性線維症、サラセミア、および癌などの障害を検出するのに有用です。

Technavioのアナリストは、2018年から2022年の間に、世界の出生前DNAシークエンシング市場が13.50%のCAGRで成長すると予測しています。

当レポートでは、世界の出生前DNAシークエンシング市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場のエコシステム
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017-2022年)

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:アプリケーション別

  • セグメンテーション:アプリケーション別
  • 比較:アプリケーション別
  • 遺伝病
  • 非遺伝病
  • 市場機会:アプリケーション別

第8章 顧客情勢

第9章 地域情勢

  • 地域別セグメンテーション
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • ヒトゲノムに関する研究活動の増加
  • DNAシーケンシングの技術向上の進展
  • 増加するM&A

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera
  • 他の有力なベンダー

第15章 付録

  • 略語のリスト
図表
  • Exhibit 01: Parent market
  • Exhibit 02: Global DNA sequencing market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global prenatal DNA sequencing market 2017-2022 ($ mn)
  • Exhibit 09: Global prenatal DNA sequencing market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Market condition - Five forces 2022
  • Exhibit 19: Global prenatal DNA sequencing market by application - Market share 2017-2022 (%)
  • Exhibit 20: Comparison by application
  • Exhibit 21: Common types of genetic disorders
  • Exhibit 22: Global prenatal DNA sequencing market by genetic diseases - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global prenatal DNA sequencing market by genetic diseases - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Global prenatal DNA sequencing market by non-genetic diseases - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Global prenatal DNA sequencing market by non-genetic diseases - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by application
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: R&D funding for cancer 2013-2016 ($ millions)
  • Exhibit 41: Cost of sequencing per genome 2001-2015 ($)
  • Exhibit 42: Prominent M&A in DNA sequencing market 2007-2014
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Agilent Technologies overview
  • Exhibit 49: Agilent Technologies - Business segments
  • Exhibit 50: Agilent Technologies - Organizational developments
  • Exhibit 51: Agilent Technologies - Geographic focus
  • Exhibit 52: Agilent Technologies - Segment focus
  • Exhibit 53: Agilent Technologies - Key offerings
  • Exhibit 54: BGI: Overview
  • Exhibit 55: BGI: Business segments
  • Exhibit 56: BGI: Organizational developments
  • Exhibit 57: BGI: Geographic focus
  • Exhibit 58: BGI: Segment focus
  • Exhibit 59: BGI: Key offerings
  • Exhibit 60: F. Hoffmann-La Roche: Overview
  • Exhibit 61: F. Hoffmann-La Roche: Business segments
  • Exhibit 62: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 63: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 64: F. Hoffmann-La Roche: Segment focus
  • Exhibit 65: F. Hoffmann-La Roche: Key offerings
  • Exhibit 66: Illumina: Overview
  • Exhibit 67: Illumina: Business segments
  • Exhibit 68: Illumina: Organizational developments
  • Exhibit 69: Illumina: Geographic focus
  • Exhibit 70: Illumina: Segment focus
  • Exhibit 71: Illumina: Key offerings
  • Exhibit 72: Laboratory Corporation of America overview
  • Exhibit 73: Laboratory Corporation of America - Business segments
  • Exhibit 74: Laboratory Corporation of America- Organizational developments
  • Exhibit 75: Laboratory Corporation of America - Geographic focus
  • Exhibit 76: Laboratory Corporation of America - Segment focus
  • Exhibit 77: Laboratory Corporation of America- Key offerings
  • Exhibit 78: Natera overview
  • Exhibit 79: Natera - Business segments
  • Exhibit 80: Natera- Organizational developments
  • Exhibit 81: Natera - Geographic focus
  • Exhibit 82: Natera - Segment focus
  • Exhibit 83: Natera - Key offerings
目次
Product Code: IRTNTR21138

About Prenatal DNA Sequencing

Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer.

Technavio's analysts forecast the global prenatal DNA sequencing market to grow at a CAGR of 13.50% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global prenatal DNA sequencing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Prenatal DNA Sequencing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera

Market driver

  • Increasing prevalence of cancer
  • For a full, detailed list, view our report

Market challenge

  • High cost of sequencing
  • For a full, detailed list, view our report

Market trend

  • Growing technological improvements in DNA sequencing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Genetic diseases
  • Non-genetic diseases
  • Market opportunity by application

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing number of research activities on human genomics
  • Growing technological improvements in DNA sequencing
  • Increasing M&A

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • BGI
  • F. Hoffmann-La Roche
  • Illumina
  • Laboratory Corporation of America
  • Natera
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations
Back to Top